JelloX Biotech, a Taiwanese startup, is at the forefront of revolutionising cancer pathology by utilising 3D digital imaging and Artificial Intelligence (AI) technology. Its 3D imaging technology demonstrates potential beyond the field of oncology. In a groundbreaking paper published in February 2023, Dr Lin-Shien Fu and colleagues from Taiwan's Taichung Veterans General Hospital showcased the innovative application of their 3D pathology in analysing kidney inflammation caused by lupus nephritis...
Urgent need for enhanced infrastructure within the medical protective gear ecosystem in India cannot be overstated...
It is estimated that over 7% of the population in Southeast Asia suffer from Chronic Respiratory Disease with asthma and COPD amongst the most common chronic respiratory diseases...
Medical Research Future Fund’s Genomics Health Futures Mission is investing $500 million in genomic medicine research...
To expand access to superspeciality critical care medicine...
Uses a simple mechanical approach for removing intrauterine tissues...
HelpMeSee has announced a new partnership with the United States Agency for International Development (USAID) American Schools and Hospitals Abroad (ASHA) Initiative to train 100 new cataract specialists to help restore sight to India's cataract blind. Through this agreement, ASHA has provided funding to deploy two HelpMeSee eye surgery simulators to facilitate training at the HelpMeSee Mumbai Centre of Excellence for Simulation-Based Training. ...
icotec, a leading medical device manufacturer specializing in BlackArmor® Carbon/PEEK spinal implants, is pleased to announce the receipt of FDA 510(k) clearance for its VADER® Pedicle System Navigated Instruments. This achievement represents a significant step forward in enhancing surgical precision and safety for spine surgeons using our innovative BlackArmor® Carbon/PEEK implants....
Study Demonstrates High Performance for Early Stage Lung Cancer Detection When Integrated with DELFI Diagnostics's Platform ...
Opportunity for broader impact as 70% of key opinion leaders interact with only one biopharma...
